QQQ   323.03 (-1.90%)
AAPL   172.19 (-1.13%)
MSFT   286.36 (-1.31%)
META   168.10 (-3.76%)
GOOGL   117.39 (-2.31%)
AMZN   138.38 (-2.75%)
TSLA   884.43 (-2.66%)
NVDA   178.48 (-4.93%)
NIO   19.09 (-4.12%)
BABA   89.72 (-1.12%)
AMD   95.25 (-5.17%)
T   18.41 (-0.11%)
MU   60.57 (-3.83%)
CGC   3.82 (+0.26%)
F   15.83 (-1.98%)
GE   77.64 (-1.98%)
DIS   120.17 (-2.04%)
AMC   17.94 (-7.00%)
PYPL   97.11 (-2.75%)
PFE   49.39 (+1.67%)
NFLX   238.50 (-2.72%)
QQQ   323.03 (-1.90%)
AAPL   172.19 (-1.13%)
MSFT   286.36 (-1.31%)
META   168.10 (-3.76%)
GOOGL   117.39 (-2.31%)
AMZN   138.38 (-2.75%)
TSLA   884.43 (-2.66%)
NVDA   178.48 (-4.93%)
NIO   19.09 (-4.12%)
BABA   89.72 (-1.12%)
AMD   95.25 (-5.17%)
T   18.41 (-0.11%)
MU   60.57 (-3.83%)
CGC   3.82 (+0.26%)
F   15.83 (-1.98%)
GE   77.64 (-1.98%)
DIS   120.17 (-2.04%)
AMC   17.94 (-7.00%)
PYPL   97.11 (-2.75%)
PFE   49.39 (+1.67%)
NFLX   238.50 (-2.72%)
QQQ   323.03 (-1.90%)
AAPL   172.19 (-1.13%)
MSFT   286.36 (-1.31%)
META   168.10 (-3.76%)
GOOGL   117.39 (-2.31%)
AMZN   138.38 (-2.75%)
TSLA   884.43 (-2.66%)
NVDA   178.48 (-4.93%)
NIO   19.09 (-4.12%)
BABA   89.72 (-1.12%)
AMD   95.25 (-5.17%)
T   18.41 (-0.11%)
MU   60.57 (-3.83%)
CGC   3.82 (+0.26%)
F   15.83 (-1.98%)
GE   77.64 (-1.98%)
DIS   120.17 (-2.04%)
AMC   17.94 (-7.00%)
PYPL   97.11 (-2.75%)
PFE   49.39 (+1.67%)
NFLX   238.50 (-2.72%)
QQQ   323.03 (-1.90%)
AAPL   172.19 (-1.13%)
MSFT   286.36 (-1.31%)
META   168.10 (-3.76%)
GOOGL   117.39 (-2.31%)
AMZN   138.38 (-2.75%)
TSLA   884.43 (-2.66%)
NVDA   178.48 (-4.93%)
NIO   19.09 (-4.12%)
BABA   89.72 (-1.12%)
AMD   95.25 (-5.17%)
T   18.41 (-0.11%)
MU   60.57 (-3.83%)
CGC   3.82 (+0.26%)
F   15.83 (-1.98%)
GE   77.64 (-1.98%)
DIS   120.17 (-2.04%)
AMC   17.94 (-7.00%)
PYPL   97.11 (-2.75%)
PFE   49.39 (+1.67%)
NFLX   238.50 (-2.72%)
LON:CTEC

ConvaTec Group - CTEC Share Forecast, Price & News

GBX 238.40
+0.40 (+0.17%)
(As of 08/19/2022 04:45 PM ET)
Add
Compare
Today's Range
236.60
240.80
50-Day Range
199
245.80
52-Week Range
165.30
256
Volume
2.12 million shs
Average Volume
3.71 million shs
Market Capitalization
£4.87 billion
P/E Ratio
7,946.67
Dividend Yield
1.92%
Price Target
GBX 253

ConvaTec Group MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
6.2% Upside
GBX 253 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.72mentions of ConvaTec Group in the last 14 days
Based on 4 Articles This Week
Insider Trading
Acquiring Shares
£4.74 M Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.21 out of 5 stars

CTEC stock logo

About ConvaTec Group (LON:CTEC) Stock

ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other urological disorders, as well as devices and products used in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospital and home healthcare markets. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Berenberg Bank reissued a "buy" rating and set a GBX 250 ($3.02) target price on shares of ConvaTec Group in a research note on Wednesday, May 18th. Barclays increased their price target on ConvaTec Group from GBX 285 ($3.44) to GBX 295 ($3.56) and gave the stock an "overweight" rating in a research report on Friday, August 5th. Royal Bank of Canada restated a "sector perform" rating and issued a GBX 210 ($2.54) price objective on shares of ConvaTec Group in a research report on Thursday, August 11th. Finally, JPMorgan Chase & Co. increased their target price on ConvaTec Group from GBX 255 ($3.08) to GBX 275 ($3.32) and gave the company an "overweight" rating in a research report on Friday, August 5th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of GBX 253 ($3.06).

ConvaTec Group Price Performance

Shares of LON:CTEC traded down GBX 1.20 ($0.01) during trading on Friday, reaching GBX 236.80 ($2.86). The stock had a trading volume of 877,772 shares, compared to its average volume of 3,705,825. The company has a debt-to-equity ratio of 90.81, a quick ratio of 0.96 and a current ratio of 1.49. ConvaTec Group has a 1-year low of GBX 165.30 ($2.00) and a 1-year high of GBX 256 ($3.09). The stock has a market cap of £4.83 billion and a PE ratio of 8,026.67. The business has a fifty day moving average price of GBX 223.98 and a 200-day moving average price of GBX 209.64.

ConvaTec Group Cuts Dividend

The firm also recently announced a dividend, which will be paid on Thursday, October 6th. Stockholders of record on Thursday, August 25th will be issued a dividend of GBX 1.41 ($0.02) per share. This represents a dividend yield of 0.61%. The ex-dividend date is Thursday, August 25th. ConvaTec Group's payout ratio is 186.71%.

Insider Activity

In other ConvaTec Group news, insider Sten Scheibye acquired 20,000 shares of the business's stock in a transaction on Monday, August 15th. The stock was bought at an average price of GBX 237 ($2.86) per share, for a total transaction of £47,400 ($57,274.05).

Receive CTEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ConvaTec Group and its competitors with MarketBeat's FREE daily newsletter.

CTEC Stock News Headlines

ConvaTec Group (LON:CTEC) PT Raised to GBX 295
Chris Gent fined £80,000 for trying his best
Convatec hires Jonny Mason as next CFO
ConvaTec Group PLC : Q3 Trading Update
ConvaTec Group PLC : Interim Results
ConvaTec Group PLC : Director/PDMR Shareholding
Scrip Dividend - Total Issued Shares
ConvaTec Group PLC : Scrip Dividend - Calculation Price
ConvaTec Group PLC - Director/PDMR Shareholding
See More Headlines
Receive CTEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ConvaTec Group and its competitors with MarketBeat's FREE daily newsletter.

CTEC Company Calendar

Last Earnings
2/28/2020
Today
8/19/2022
Ex-Dividend for 10/6 Dividend
8/25/2022
Dividend Payable
10/06/2022

Industry, Sector and Symbol

Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
10,142
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
GBX 253
High Stock Price Forecast
GBX 295
Low Stock Price Forecast
GBX 210
Forecasted Upside/Downside
+6.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
6 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£2.07 billion
Cash Flow
GBX 13.59 per share
Book Value
GBX 78.40 per share

Miscellaneous

Outstanding Shares
2,041,765,000
Free Float
N/A
Market Cap
£4.87 billion
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Karim Bitar (Age 57)
    CEO & Director
    Comp: $3.48M
  • Mr. Frank M. Schulkes (Age 60)
    Exec. Officer
    Comp: $1.08M
  • Mr. Jonathan P. Mason (Age 58)
    Group CFO & Director
  • Mr. Donal Balfe
    Exec. VP and Chief of Quality & Operations
  • Dr. Divakar Ramakrishnan Ph.D.
    Exec. VP & Chief Technology Officer
  • Mr. Mark Reynolds
    Director of Investor Relations
  • Ms. Kate Postans
    VP of Investor Relations & Corp. Communications
  • Ms. Natalia Kozmina
    Exec. VP & Chief HR Officer
  • Mr. Christian Hoengaard
    Sr. VP & GM - USA
  • Ms. Kjersti Grimsrud Biotechnology (Age 61)
    M.Sc., Pres & COO of Infusion Care













CTEC Stock - Frequently Asked Questions

Should I buy or sell ConvaTec Group stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ConvaTec Group in the last twelve months. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CTEC shares.
View CTEC analyst ratings
or view top-rated stocks.

What is ConvaTec Group's stock price forecast for 2022?

6 equities research analysts have issued 12 month price targets for ConvaTec Group's shares. Their CTEC share price forecasts range from GBX 210 to GBX 295. On average, they predict the company's stock price to reach GBX 253 in the next year. This suggests a possible upside of 6.2% from the stock's current price.
View analysts price targets for CTEC
or view top-rated stocks among Wall Street analysts.

How have CTEC shares performed in 2022?

ConvaTec Group's stock was trading at GBX 193.15 at the start of the year. Since then, CTEC shares have increased by 23.3% and is now trading at GBX 238.20.
View the best growth stocks for 2022 here
.

How were ConvaTec Group's earnings last quarter?

ConvaTec Group Plc (LON:CTEC) announced its earnings results on Friday, February, 28th. The company reported $12.00 earnings per share for the quarter, missing analysts' consensus estimates of $12.70 by $0.70.

How often does ConvaTec Group pay dividends? What is the dividend yield for ConvaTec Group?

ConvaTec Group announced a dividend on Thursday, August 4th. Stockholders of record on Thursday, August 25th will be given a dividend of GBX 1.41 per share on Thursday, October 6th. This represents a dividend yield of 0.61%. The ex-dividend date is Thursday, August 25th. The official announcement can be seen at this link.
Read our dividend analysis for CTEC
.

Is ConvaTec Group a good dividend stock?

ConvaTec Group (LON:CTEC) pays an annual dividend of GBX 0.06 per share and currently has a dividend yield of 1.92%. The dividend payout ratio is 186.71%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for CTEC.

What other stocks do shareholders of ConvaTec Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ConvaTec Group investors own include EnQuest (ENQ), Centamin (CEY), Oxford Biomedica (OXB), Bristol-Myers Squibb (BMY), Andalas Energy and Power (ADL), AFR.L (AFR), CBTX (CBTX), Genel Energy (GENL), Premier Oil (PMO) and Playtech (PTEC).

What is ConvaTec Group's stock symbol?

ConvaTec Group trades on the London Stock Exchange (LON) under the ticker symbol "CTEC."

How do I buy shares of ConvaTec Group?

Shares of CTEC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is ConvaTec Group's stock price today?

One share of CTEC stock can currently be purchased for approximately GBX 238.20.

How much money does ConvaTec Group make?

ConvaTec Group (LON:CTEC) has a market capitalization of £4.86 billion and generates £2.07 billion in revenue each year.

How many employees does ConvaTec Group have?

The company employs 10,142 workers across the globe.

How can I contact ConvaTec Group?

ConvaTec Group's mailing address is 3 Forbury Place Floor 7, 23 Forbury Road, ICKENHAM, RG1 3JH, United Kingdom. The official website for the company is www.convatecgroup.com. The company can be reached via phone at 44 11 8952 8100.

This page (LON:CTEC) was last updated on 8/19/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.